To receive important alerts and updates from Gold Coast Primary Health Network, please submit the form below.
To receive important alerts and updates from Gold Coast Primary Health Network, please submit the form below.
The Activating Primary Care COPD Patients with Multimorbidity (APCOM) Trial is a randomized controlled clinical trial that aims to test a personalised self-management support program, to be delivered by Practice Nurses (PNs) to patients with COPD and other long-term health conditions.
The trial will evaluate whether this program is effective in improving quality of life, increasing patient knowledge of COPD and can be effectively implemented in primary care.
The APCOM Trial is being conducted by Bond University, UNSW Sydney, University of Queensland, Woolcock Institute of Medical Research, University of Wollongong Australia and University of Sydney in collaboration with Lung Foundation Australia, Australian Primary Health Care Nurses Association and the Royal Australian College of General Practitioners (Ethics Approval No.SA02927).
What do you need to do?
Recompense for participating in the trial
In addition to the above, PNs and GPs from all participating practices can claim CPD points towards their involvement in the trial.
How to get involved?
Preventing Adverse Cardiac Events (PACE) in Chronic Obstructive Pulmonary Disease (COPD) is conducting a study in Australia and New Zealand. In this study, PACE in COPD will be investigating whether long-term (two-year) drug treatment of heart disease in COPD can reduce cardiac events, such as strok...
So we can provide you with the most accurate information,
please tell us a little more about yourself